Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_assertion description "[Moreover, agents targeting bone biology (eg, zoledronic acid, anti-DKK-1 MoAb, anti-B-cell activating factor MoAb and bortezomib, Btk inhibitor) show promise not only in preserving bone integrity but also against MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_assertion evidence source_evidence_literature NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_assertion SIO_000772 22215754 NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_assertion wasDerivedFrom befree-20150227 NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_assertion wasGeneratedBy ECO_0000203 NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP851285.RA5slgPb0HhpOB62F-qD8FZd8KTVrovmVyCTdBi4RBLTQ130_provenance.